Advertisement

The Athlete’s Heart: Cardiovascular Disease in the Athlete

  • Jodi L. Zilinski
  • Aaron L. BaggishEmail author
Chapter

Abstract

With the rising popularity of recreational and competitive athletics, clinicians will benefit from an understanding of the unique physiology, clinical presentations, and management of highly trained athletes. Cardiac enlargement in athletes has been documented since the late 1800s and our understanding of the “athlete’s heart” continues to advance as cardiovascular diagnostic technology improves. The term exercise-induced cardiac remodeling has been used to describe the significant changes in myocardial structure and function that result from repeated exposure to vigorous physical exercise. In clinical practice, these adaptations can be encountered during the physical examination and are clearly manifest on the electrocardiogram and during echocardiography of trained athletes. The approach to the athlete with symptoms including chest pain, syncope, or palpitation, all common in this population, requires a careful medical history with thorough assessment of athlete-specific topics including training regimen, competition history, and inquiry about performance-enhancing agents. This review provides an up-to-date summary of the science of cardiac remodeling in athletes as well as an overview of common clinical issues that are encountered in the cardiovascular care of the athlete.

Keywords

Athletes Exercise-induced cardiac remodeling Syncope Chest pain Palpitations 

References

  1. 1.
    Osler W. The principles and practice of medicine. New York: Appleton and Company; 1892.Google Scholar
  2. 2.
    Karpovich PV. Textbook fallacies regarding child’s heart. Res Quart. 1937;8:33.Google Scholar
  3. 3.
    Darling E. The effects of training: a study of the Harvard University crews. Boston Med Surg J. 1899;161:229–33.CrossRefGoogle Scholar
  4. 4.
    Henschen S. Skilauf und Skiwettlauf. Eine medizinische Sportstudie. Mitt Med Klinik Upsala. 1899;2:15–8.Google Scholar
  5. 5.
    Deutsch F, Kauf E. Heart and athletics. St. Louis: CV Mosby Company; 1927.Google Scholar
  6. 6.
    Baggish AL, Wood MJ. Athlete’s heart and cardiovascular care of the athlete: scientific and clinical update. Circulation. 2011;123:2723–35.PubMedCrossRefGoogle Scholar
  7. 7.
    Thompson PD, editor. Exercise and sports cardiology. New York: McGraw-Hill; 2001.Google Scholar
  8. 8.
    Thompson PD. Exercise prescription and proscription for patients with coronary artery disease. Circulation. 2005;112:2354–63.PubMedCrossRefGoogle Scholar
  9. 9.
    Astrand P, Rodahl K. Textbook of work physiology. New York: McGraw-Hill Book Company; 1977.Google Scholar
  10. 10.
    Jose AD, Collison D. The normal range and determinants of the intrinsic heart rate in man. Cardiovasc Res. 1970;4:160–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Uusitalo AL, Uusitalo AJ, Rusko HK. Exhaustive endurance training for 6–9 weeks did not induce changes in intrinsic heart rate and cardiac autonomic modulation in female athletes. Int J Sports Med. 1998;19:532–40.PubMedCrossRefGoogle Scholar
  12. 12.
    Weiner RB, Baggish AL. Exercise-induced cardiac remodeling. Prog Cardiovasc Dis. 2012;54:380–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Venerando A, Rulli V. Frequency morphology and meaning of the electrocardiographic anomalies found in Olympic marathon runners and walkers. J Sports Med Phys Fitness. 1964;50:135–41.PubMedGoogle Scholar
  14. 14.
    Roeske WR, O’Rourke RA, Klein A, Leopold G, Karliner JS. Noninvasive evaluation of ventricular hypertrophy in professional athletes. Circulation. 1976;53:286–91.PubMedCrossRefGoogle Scholar
  15. 15.
    Pelliccia A, Culasso F, Di Paolo FM, Maron BJ. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med. 1999;130:23–31.PubMedCrossRefGoogle Scholar
  16. 16.
    Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med. 1991;324:295–301.PubMedCrossRefGoogle Scholar
  17. 17.
    Baggish AL, Yared K, Weiner RB, et al. Differences in cardiac parameters among elite rowers and subelite rowers. Med Sci Sports Exerc. 2010;42:1215–20.PubMedGoogle Scholar
  18. 18.
    Baggish AL, Wang F, Weiner RB, et al. Training-specific changes in cardiac structure and function: a prospective and longitudinal assessment of competitive athletes. J Appl Physiol. 2008;104:1121–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Caso P, D’Andrea A, Galderisi M, et al. Pulsed Doppler tissue imaging in endurance athletes: relation between left ventricular preload and myocardial regional diastolic function. Am J Cardiol. 2000;85:1131–6.PubMedCrossRefGoogle Scholar
  20. 20.
    D’Andrea A, Cocchia R, Riegler L, et al. Left ventricular myocardial velocities and deformation indexes in top-level athletes. J Am Soc Echocardiogr. 2010;23:1281–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Prasad A, Popovic ZB, Arbab-Zadeh A, et al. The effects of aging and physical activity on Doppler measures of diastolic function. Am J Cardiol. 2007;99:1629–36.PubMedCrossRefGoogle Scholar
  22. 22.
    Baggish AL, Yared K, Wang F, et al. The impact of endurance exercise training on left ventricular systolic mechanics. Am J Physiol Heart Circ Physiol. 2008;295:H1109–16.PubMedCrossRefGoogle Scholar
  23. 23.
    Weiner RB, Hutter Jr AM, Wang F, et al. The impact of endurance exercise training on left ventricular torsion. JACC Cardiovasc Imaging. 2010;3:1001–9.PubMedCrossRefGoogle Scholar
  24. 24.
    D’Andrea A, Riegler L, Golia E, et al. Range of right heart measurements in top-level athletes: the training impact. Int J Cardiol. 2013;164(1):48–57.PubMedCrossRefGoogle Scholar
  25. 25.
    Oxborough D, Sharma S, Shave R, et al. The right ventricle of the endurance athlete: the relationship between morphology and deformation. J Am Soc Echocardiogr. 2012;25:263–71.PubMedCrossRefGoogle Scholar
  26. 26.
    Scharhag J, Schneider G, Urhausen A, Rochette V, Kramann B, Kindermann W. Athlete’s heart: right and left ventricular mass and function in male endurance athletes and untrained individuals determined by magnetic resonance imaging. J Am Coll Cardiol. 2002;40:1856–63.PubMedCrossRefGoogle Scholar
  27. 27.
    Pelliccia A, Maron BJ, Di Paolo FM, et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol. 2005;46:690–6.PubMedCrossRefGoogle Scholar
  28. 28.
    D’Andrea A, Riegler L, Cocchia R, et al. Left atrial volume index in highly trained athletes. Am Heart J. 2010;159:1155–61.PubMedCrossRefGoogle Scholar
  29. 29.
    Wilhelm M, Roten L, Tanner H, Wilhelm I, Schmid JP, Saner H. Atrial remodeling, autonomic tone, and lifetime training hours in nonelite athletes. Am J Cardiol. 2011;108:580–5.PubMedCrossRefGoogle Scholar
  30. 30.
    World Anti-doping agency. The World Anti-Doping Code: The 2013 Prohibited List. 2013; http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/2013/WADA-Prohibited-List-2013-EN.pdf (accessed October 9, 2013).
  31. 31.
    Kiraly CL. Androgenic-anabolic steroid effects on serum and skin surface lipids, on red cells, and on liver enzymes. Int J Sports Med. 1988;9:249–52.PubMedCrossRefGoogle Scholar
  32. 32.
    Riebe D, Fernhall B, Thompson PD. The blood pressure response to exercise in anabolic steroid users. Med Sci Sports Exerc. 1992;24:633–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Baggish AL, Weiner RB, Kanayama G, et al. Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction. Circ Heart Fail. 2010;3:472–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Perron AD. Chest pain in athletes. Clin Sports Med. 2003;22:37–50.PubMedCrossRefGoogle Scholar
  35. 35.
    Leon AS, Connett J, Jacobs Jr DR, Rauramaa R. Leisure-time physical activity levels and risk of coronary heart disease and death. The multiple risk factor intervention trial. JAMA. 1987;258:2388–95.PubMedCrossRefGoogle Scholar
  36. 36.
    Blair SN, Kohl 3rd HW, Paffenbarger Jr RS, Clark DG, Cooper KH, Gibbons LW. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA. 1989;262:2395–401.PubMedCrossRefGoogle Scholar
  37. 37.
    Kannel WB, Wilson P, Blair SN. Epidemiological assessment of the role of physical activity and fitness in development of cardiovascular disease. Am Heart J. 1985;109:876–85.PubMedCrossRefGoogle Scholar
  38. 38.
    Kim JH, Malhotra R, Chiampas G, et al. Cardiac arrest during long-distance running races. N Engl J Med. 2012;366:130–40.PubMedCrossRefGoogle Scholar
  39. 39.
    Engelstein ED, Zipes DP. Sudden cardiac death. In: Alexander RW, Schlant RC, Fuster V, editors. The heart, arteries, and veins. New York: McGraw-Hill; 1998. p. 1081–112.Google Scholar
  40. 40.
    Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to update the 1997 exercise testing guidelines). Circulation. 2002;106:1883–92.PubMedCrossRefGoogle Scholar
  41. 41.
    Medicine. ACoS. Guidelines for exercise testing and prescription. 7th ed. Baltimore: Lippincott Williams & Wilkins; 2005.Google Scholar
  42. 42.
    Thompson PD, Balady GJ, Chaitman BR, Clark LT, Levine BD, Myerburg RJ. Task force 6: coronary artery disease. J Am Coll Cardiol. 2005;45:1348–53.PubMedCrossRefGoogle Scholar
  43. 43.
    Baggish AL, Thompson PD. The Athlete’s heart 2007: diseases of the coronary circulation. Cardiol Clin. 2007;25:431–40, vi.PubMedCrossRefGoogle Scholar
  44. 44.
    Maron BJ, Epstein SE, Roberts WC. Causes of sudden death in competitive athletes. J Am Coll Cardiol. 1986;7:204–14.PubMedCrossRefGoogle Scholar
  45. 45.
    Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA. 1996;276:199–204.PubMedCrossRefGoogle Scholar
  46. 46.
    Corrado D, Thiene G, Nava A, Rossi L, Pennelli N. Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. Am J Med. 1990;89:588–96.PubMedCrossRefGoogle Scholar
  47. 47.
    Singh AM, McGregor RS. Differential diagnosis of chest symptoms in the athlete. Clin Rev Allergy Immunol. 2005;29:87–96.PubMedCrossRefGoogle Scholar
  48. 48.
    Levy AS, Bassett F, Lintner S, Speer K. Pulmonary barotrauma: diagnosis in American football players. Three cases in three years. Am J Sports Med. 1996;24:227–9.PubMedCrossRefGoogle Scholar
  49. 49.
    Wellens HJ. Early repolarization revisited. N Engl J Med. 2008;358:2063–5.PubMedCrossRefGoogle Scholar
  50. 50.
    Noseworthy PA, Weiner R, Kim J, et al. Early repolarization pattern in competitive athletes: clinical correlates and the effects of exercise training. Circ Arrhythm Electrophysiol. 2011;4:432–40.PubMedCrossRefGoogle Scholar
  51. 51.
    Hanne-Paparo N, Drory Y, Schoenfeld Y, Shapira Y, Kellermann JJ. Common ECG changes in athletes. Cardiology. 1976;61:267–78.PubMedCrossRefGoogle Scholar
  52. 52.
    Huston TP, Puffer JC, Rodney WM. The athletic heart syndrome. N Engl J Med. 1985;313:24–32.PubMedCrossRefGoogle Scholar
  53. 53.
    Parker MW, Thompson PD. Assessment and management of atherosclerosis in the athletic patient. Prog Cardiovasc Dis. 2012;54:416–22.PubMedCrossRefGoogle Scholar
  54. 54.
    Kushner FG, Hand M, Smith Jr SC, et al. Focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009;2009(120):2271–306.CrossRefGoogle Scholar
  55. 55.
    Wright RS, Anderson JL, Adams CD, et al. ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;2011(123):2022–60.Google Scholar
  56. 56.
    Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina – summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee on the management of patients with chronic stable angina). Circulation. 2003;107:149–58.PubMedCrossRefGoogle Scholar
  57. 57.
    Smith Jr SC, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011;124:2458–73.PubMedCrossRefGoogle Scholar
  58. 58.
    Bruckert E, Hayem G, Dejager S, Yau C, Begaud B. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients – the PRIMO study. Cardiovasc Drugs Ther. 2005;19:403–14.PubMedCrossRefGoogle Scholar
  59. 59.
    Sinzinger H, O’Grady J. Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems. Br J Clin Pharmacol. 2004;57:525–8.PubMedCrossRefGoogle Scholar
  60. 60.
    Meador BM, Huey KA. Statin-associated myopathy and its exacerbation with exercise. Muscle Nerve. 2010;42:469–79.PubMedCrossRefGoogle Scholar
  61. 61.
    Ford I, Murray H, Packard CJ, Shepherd J, Macfarlane PW, Cobbe SM. Long-term follow-up of the West of Scotland coronary prevention study. N Engl J Med. 2007;357:1477–86.PubMedCrossRefGoogle Scholar
  62. 62.
    Fuller CM, McNulty CM, Spring DA, et al. Prospective screening of 5,615 high school athletes for risk of sudden cardiac death. Med Sci Sports Exerc. 1997;29:1131–8.PubMedCrossRefGoogle Scholar
  63. 63.
    Biffi A, Pelliccia A, Verdile L, et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol. 2002;40:446–52.PubMedCrossRefGoogle Scholar
  64. 64.
    Lawless CE, Briner W. Palpitations in athletes. Sports Med. 2008;38:687–702.PubMedCrossRefGoogle Scholar
  65. 65.
    Stein R, Medeiros CM, Rosito GA, Zimerman LI, Ribeiro JP. Intrinsic sinus and atrioventricular node electrophysiologic adaptations in endurance athletes. J Am Coll Cardiol. 2002;39:1033–8.PubMedCrossRefGoogle Scholar
  66. 66.
    Baldesberger S, Bauersfeld U, Candinas R, et al. Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists. Eur Heart J. 2008;29:71–8.PubMedCrossRefGoogle Scholar
  67. 67.
    Furlanello F, Bertoldi A, Dallago M, et al. Atrial fibrillation in elite athletes. J Cardiovasc Electrophysiol. 1998;9:S63–8.PubMedGoogle Scholar
  68. 68.
    Abdulla J, Nielsen JR. Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. Europace. 2009;11:1156–9.PubMedCrossRefGoogle Scholar
  69. 69.
    Molina L, Mont L, Marrugat J, et al. Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study. Europace. 2008;10:618–23.PubMedCrossRefGoogle Scholar
  70. 70.
    Sorokin AV, Araujo CG, Zweibel S, Thompson PD. Atrial fibrillation in endurance-trained athletes. Br J Sports Med. 2011;45:185–8.PubMedCrossRefGoogle Scholar
  71. 71.
    Mont L, Elosua R, Brugada J. Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter. Europace. 2009;11:11–7.PubMedCrossRefGoogle Scholar
  72. 72.
    Wilhelm M, Roten L, Tanner H, Schmid JP, Wilhelm I, Saner H. Long-term cardiac remodeling and arrhythmias in nonelite marathon runners. Am J Cardiol. 2012;110:129–35.PubMedCrossRefGoogle Scholar
  73. 73.
    Turagam MK, Velagapudi P, Kocheril AG. Atrial fibrillation in athletes. Am J Cardiol. 2012;109:296–302.PubMedCrossRefGoogle Scholar
  74. 74.
    Zipes DP, Ackerman MJ, Estes 3rd NA, Grant AO, Myerburg RJ, Van Hare G. Task force 7: arrhythmias. J Am Coll Cardiol. 2005;45:1354–63.PubMedCrossRefGoogle Scholar
  75. 75.
    Biffi A, Maron BJ, Verdile L, et al. Impact of physical deconditioning on ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol. 2004;44:1053–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Brignole M, Alboni P, Benditt DG, et al. Guidelines on management (diagnosis and treatment) of syncope – update 2004. Europace. 2004;6:467–537.PubMedCrossRefGoogle Scholar
  77. 77.
    Barold SS, Padeletti L. Mobitz type II second-degree atrioventricular block in athletes: true or false? Br J Sports Med. 2011;45:687–90.PubMedCrossRefGoogle Scholar
  78. 78.
    Koopman P, Nuyens D, Garweg C, et al. Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation. Europace. 2011;13:1386–93.PubMedCrossRefGoogle Scholar
  79. 79.
    Kelly J, Kenny D, Martin RP, Stuart AG. Diagnosis and management of elite young athletes undergoing arrhythmia intervention. Arch Dis Child. 2011;96:21–4.PubMedCrossRefGoogle Scholar
  80. 80.
    Hastings JL, Levine BD. Syncope in the athletic patient. Prog Cardiovasc Dis. 2012;54:438–44.PubMedCrossRefGoogle Scholar
  81. 81.
    Link MS, Estes 3rd NA. How to manage athletes with syncope. Cardiol Clin. 2007;25:457–66, vii.PubMedCrossRefGoogle Scholar
  82. 82.
    Linzer M, Yang EH, Estes 3rd NA, Wang P, Vorperian VR, Kapoor WN. Diagnosing syncope. Part 1: value of history, physical examination, and electrocardiography. Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med. 1997;126:989–96.PubMedCrossRefGoogle Scholar
  83. 83.
    Colivicchi F, Ammirati F, Santini M. Epidemiology and prognostic implications of syncope in young competing athletes. Eur Heart J. 2004;25:1749–53.PubMedCrossRefGoogle Scholar
  84. 84.
    Freeman R. Clinical practice. Neurogenic orthostatic hypotension. N Engl J Med. 2008;358:615–24.PubMedCrossRefGoogle Scholar
  85. 85.
    Goldschlager N, Epstein AE, Grubb BP, et al. Etiologic considerations in the patient with syncope and an apparently normal heart. Arch Intern Med. 2003;163:151–62.PubMedCrossRefGoogle Scholar
  86. 86.
    Benditt DG, Remole S, Milstein S, Bailin S. Syncope: causes, clinical evaluation, and current therapy. Annu Rev Med. 1992;43:283–300.PubMedCrossRefGoogle Scholar
  87. 87.
    Calkins H, Seifert M, Morady F. Clinical presentation and long-term follow-up of athletes with exercise-induced vasodepressor syncope. Am Heart J. 1995;129:1159–64.PubMedCrossRefGoogle Scholar
  88. 88.
    Calkins H, Shyr Y, Frumin H, Schork A, Morady F. The value of the clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block, and neurocardiogenic syncope. Am J Med. 1995;98:365–73.PubMedCrossRefGoogle Scholar
  89. 89.
    Kapoor WN. Current evaluation and management of syncope. Circulation. 2002;106:1606–9.PubMedCrossRefGoogle Scholar
  90. 90.
    Sheldon R, Rose S, Ritchie D, et al. Historical criteria that distinguish syncope from seizures. J Am Coll Cardiol. 2002;40:142–8.PubMedCrossRefGoogle Scholar
  91. 91.
    Pelliccia A, Maron BJ, Culasso F, et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation. 2000;102:278–84.PubMedCrossRefGoogle Scholar
  92. 92.
    Lawless CE, Best TM. Electrocardiograms in athletes: interpretation and diagnostic accuracy. Med Sci Sports Exerc. 2008;40:787–98.PubMedCrossRefGoogle Scholar
  93. 93.
    Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Circulation. 2009;119:1085–92.PubMedCrossRefGoogle Scholar
  94. 94.
    Verma S, Hackel JG, Torrisi DJ, Nguyen T. Syncope in athletes: a guide to getting them back on their feet. J Fam Pract. 2007;56:545–50.PubMedGoogle Scholar
  95. 95.
    Prakken NH, Velthuis BK, Cramer MJ, Mosterd A. Advances in cardiac imaging: the role of magnetic resonance imaging and computed tomography in identifying athletes at risk. Br J Sports Med. 2009;43:677–84.PubMedCrossRefGoogle Scholar
  96. 96.
    Romme JJ, Reitsma JB, Black CN, et al. Drugs and pacemakers for vasovagal, carotid sinus and situational syncope. Cochrane Database Syst Rev. 2011:CD004194.Google Scholar
  97. 97.
    Benditt DG, Nguyen JT. Syncope: therapeutic approaches. J Am Coll Cardiol. 2009;53:1741–51.PubMedCrossRefGoogle Scholar
  98. 98.
    Heidbuchel H. Implantable cardioverter defibrillator therapy in athletes. Cardiol Clin. 2007;25:467–82, vii.PubMedCrossRefGoogle Scholar
  99. 99.
    Lampert R, Olshansky B, Heidbuchel H, et al. Safety of sports for athletes with implantable cardioverter-defibrillators: results of a prospective, multinational registry. Circulation. 2013;127:2021–2030.Google Scholar

Copyright information

© Springer-Verlag London 2014

Authors and Affiliations

  1. 1.Department of CardiologyMassachusetts General HospitalBostonUSA

Personalised recommendations